| For: | Yuan JX, Jiang Q, Yu SJ. Diabetes mellitus and prostate cancer risk: A mendelian randomization analysis. World J Diabetes 2023; 14(12): 1839-1848 [PMID: 38222791 DOI: 10.4239/wjd.v14.i12.1839] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v14/i12/1839.htm |
| Number | Citing Articles |
| 1 |
Jian Li, Zhi-Peng Li, Si-Si Xu, Wei Wang. Unraveling the biological link between diabetes mellitus and prostate cancer: Insights and implications. World Journal of Diabetes 2024; 15(6): 1367-1373 doi: 10.4239/wjd.v15.i6.1367
|
| 2 |
Shubin Wang, Teng Pan, Shuya Wang, Xiaokun Zhang, Li Peng, Wuhan Yang. Impact of preoperative blood glucose levels on prognosis and postoperative complications in patients with pancreatic cancer. Oncology Letters 2025; 29(3) doi: 10.3892/ol.2025.14880
|
| 3 |
Sen Pan, Chuanlin Wang, Wei Sun, Xin Zhang. Association between vitamin intake and prostate cancer: a cross-sectional study. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1607452
|
| 4 |
Zhongtao Bai, Genlong Zhang. The application of mendelian randomization in cancer research: a bibliometric analysis. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02226-7
|
| 5 |
Qiujin Zhu, Shangheng Fan, Jingru Mou, Manlu Zhao, Changlu Li, Benben Yang, Yihan Shangguan, Xia Chen, Yulan Cai. Comprehensive Analysis Reveals Biomarkers Related to Diabetic Peripheral Neuropathy and Its Molecular Mechanism. International Journal of General Medicine 2025; : 6551 doi: 10.2147/IJGM.S544464
|
